In the head and neck squamous cell carcinoma, treatment with the NLRP3 inhibitor MCC950 decreased sphere and colony formation as well as cancer stem cell marker BMI1, ALDH1, and CD44 expression 49. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.